ArticleHereditary cancer in clinical practice2022

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland.

Elżbieta Złowocka-Perłowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.